NCT05680454 2023-01-17A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV VaccineBeijing Health Guard Biotechnology, IncPhase 1 Completed160 enrolled
NCT03677960 2019-07-24Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) InfectionAntiva BiosciencesPhase 1 Terminated6 enrolled
NCT03202992 2019-02-07Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) InfectionAntiva BiosciencesPhase 1 Completed57 enrolled